SCIENTURE
Scienture is an operator of a pharmaceutical research company used to focus on drug screening. It focuses on the research and development of specialty product concepts that enable researchers to focus on the advancement of novel drugs in areas of unmet medical needs. The company's assets in development are across therapeutics areas, indications, and cater to different market segments focusing on the unmet medical needs of patients through innovative pharmaceutical products.
SCIENTURE
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Hauppauge, New York, United States
Country:
United States
Website Url:
http://www.scienture.com
Total Employee:
1+
Status:
Active
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Official Site Inspections
http://www.scienture.com
- Host name: 68.183.20.97
- IP address: 68.183.20.97
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Scienture"
Scienture LLC
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan …See details»
Scienture Holdings
Scienture, LLC is a New York-based pharmaceutical company driven by a highly experienced team passionate about developing unique specialty products that bring enhanced value to …See details»
Scienture - Crunchbase Company Profile & Funding
Scienture is an operator of a pharmaceutical research company used to focus on drug screening. It focuses on the research and development of specialty …See details»
Scienture LLC - LinkedIn
Scienture LLC, a fully owned subsidiary of Scienture Holdings, Inc., is a NY based pharmaceutical research company. We are a highly experienced team of industry professionals who are passionate ...See details»
Scienture - Products, Competitors, Financials, Employees, …
Scienture is a pharmaceutical company focused on developing pharmaceutical products. Use the CB Insights Platform to explore Scienture's full profile. Technology Vendors ... a leading …See details»
Scienture - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 11, 2025 Scienture is a public company based in Hauppauge (United States), founded in 2019 by Shankar Hariharan. It operates as a Developer of therapeutics for CNS, oncology, …See details»
Company - Scienture LLC
Before joining Amneal, Dr. Hariharan founded DermAct, an R&D organization specializing in new molecule discovery and product development for key indications in Dermatology, leading to …See details»
SCIENTURE Announces Commercial Operations Leadership and …
Mar 25, 2025 SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization Scienture Holdings, …See details»
Investors - Scienture Holdings
Scienture Holdings, Inc. (NASDAQ: SCNX) holds existing and planned pharmaceutical operating companies. Focused on providing enhanced value to patients, physicians, and caregivers …See details»
Scienture 2025 Company Profile: Stock Performance & Earnings
Scienture General Information Description. Operator of a pharmaceutical research company intended to focus on drug screening. The company focuses on research and development of …See details»
SCIENTURE announces FDA Orange Book Patent Listing for
6 hours ago Scienture Holdings, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that …See details»
Scienture Holdings - Crunchbase Company Profile & Funding
Scienture is a pharmaceutical company focused on solving real-world problems in healthcare. The company is providing efficient integrated pharmaceutical and medical services to pharmacies …See details»
Science - Scienture LLC
Scienture LLC. We fuse our core capabilities to critical cornerstones, providing scientific and commercial solutions that address therapy treatment gaps and lead to better health outcomes. …See details»
Scienture Holdings, Inc. Issues Annual Letter to Shareholders
Apr 3, 2025 Scienture, LLC’s Story. Scienture, LLC (previously known as Scienture, Inc.) was founded in June 2019 as a branded specialty pharmaceutical company with a mission to …See details»
SCIENTURE Announces Commercial Operations Leadership and …
Mar 25, 2025 Under Ms. Rath’s leadership, Scienture, LLC has formalized a strategic relationship with Syneos Health Commercial Services, LLC (“Syneos Health”), a premier …See details»
About - Scienture Holdings
Before joining Amneal, Dr. Hariharan founded DermAct, an R&D organization specializing in new molecule discovery and product development for key indications in Dermatology, leading to …See details»
SCIENTURE Announces Commercial Operations ... - The Globe and …
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization Scienture Holdings, Inc. - …See details»
Products - Scienture LLC
At Scienture, we value bold ideas grounded in evidence-based solutions, balancing innovation with measurable impact on patient care. Contact us to explore partnership opportunities in …See details»
Contact - Scienture LLC
Scienture LLC. 20 Austin Boulevard Commack, New York 11725 631.670.6039. Get Directions. Careers. Submit your resume to join us in shaping the future of healthcare. View Job Posts. …See details»
Newsroom - Scienture LLC
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan …See details»